|
Should I See You Again Soon? A Multispecialty Assessment of the Impact and Burden of Preoperative History and Physical Update Visits
|
March 8, 2024
|
PC3I Authors |
Journal of the American College of Surgeons
|
|
The unique risk factor profile of triple negative breast cancer: a comprehensive meta-analysis
|
March 6, 2024
|
PC3I Authors Anne Marie McCarthy; Oluwadamilola "Lola" Fayanju |
Journal of the National Cancer Institute
|
|
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
|
March 3, 2024
|
PC3I Authors Charu Aggarwal |
Lung Cancer (Amsterdam, Netherlands)
|
|
Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?
|
March 1, 2024
|
PC3I Authors Roger Kim |
Cancer Biomarkers
|
|
Racial and Ethnic Disparities in Breast Cancer: A Collaboration Between the American College of Radiology Commissions on Women and Diversity and Breast Imaging
|
March 1, 2024
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Journal of Breast Imaging
|
|
The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors
|
February 28, 2024
|
PC3I Authors Angela Bradbury |
BMC Health Services Research
|
|
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy
|
February 28, 2024
|
PC3I Authors Ronac Mamtani |
European Urology
|
|
Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship
|
February 27, 2024
|
PC3I Authors Alix Seif |
Pediatric Blood & Cancer
|
|
The global burden of cervical cancer requiring surgery: database estimates
|
February 26, 2024
|
PC3I Authors Surbhi Grover |
Infectious Agents and Cancer
|
|
Artificial intelligence and technology collaboratories: Empowering innovation in AI + AgeTech
|
February 26, 2024
|
PC3I Authors George Demiris |
Journal of the American Geriatrics Society
|
|
Five-Year Outcomes of a Phase 1/2 Trial of Accelerated Partial Breast Irradiation Using Proton Therapy for Women With Stage 0-IIA Breast Cancer
|
February 26, 2024
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Advances in Radiation Oncology
|
|
Prior authorization for FDA-approved PARP inhibitors in ovarian cancer
|
February 23, 2024
|
PC3I Authors Anna Jo Smith; Emily Ko |
Gynecologic Oncology Reports
|
|
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumor-only versus paired tumor-normal sequencing
|
February 22, 2024
|
PC3I Authors |
Haematologica
|
|
The impact of an oncology urgent care center on healthcare utilization
|
February 20, 2024
|
PC3I Authors Christopher A. D’Avella |
JNCI Cancer Spectrum
|
|
Sex differences and racial/ethnic disparities in the presentation and treatment of medullary thyroid cancer
|
February 16, 2024
|
PC3I Authors |
American Journal of Surgery
|
|
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
|
February 16, 2024
|
PC3I Authors Melina Marmarelis |
JTO Clinical and Research Reports
|
|
Belonging in Surgery: A validated instrument and single institutional pilot
|
February 13, 2024
|
PC3I Authors |
Annals of Surgery
|
|
Comorbid Dementia and Cancer Therapy Decision-Making: A Scoping Review
|
February 13, 2024
|
PC3I Authors Tamara J. Cadet |
Journal of Applied Gerontology
|
|
Financial toxicity in gynecologic oncology: a multi-practice survey
|
February 12, 2024
|
PC3I Authors Anna Jo Smith; Meredith Doherty; Emily Ko |
International Journal of Gynecological Cancer
|
|
Cancer burden in low-income and middle-income countries
|
February 9, 2024
|
PC3I Authors Surbhi Grover |
Nature Reviews. Cancer
|
